New Zealand agritech company AbacusBio has announced a partnership with Bayer CropScience to enhance predictive plant breeding.
Under the agreement, Bayer will incorporate AbacusBio’s leading expertise in trait prioritisation and valuation to advance products which anticipate grower and market needs.
AbacusBio says through computational integration of bioeconomic, trait preference and sociodemographic data, its technology can improve predictions which influence trait improvement priorities, market segmentation and economic potential.
Commenting on the news, Dr Mike Graham, head of plant breeding for Bayer CropScience said: “We anticipate we will be able to accelerate our annual rate of genetic gain through AbacusBio’s platform, which will enable more effective use of the detailed data we collect on a very broad range of candidate traits.
“One of the key factors that underpins the success of genetic improvement programs is balancing genetic gain across a combination of traits to meet production, quality and sustainability needs in the market,”
AbacusBio partner and project lead Dr Tim Byrne added: “This is why we’ll be working directly with scientists, commercial growers, seed retailers and other stakeholders across the supply chain. We want to bring their knowledge and experience with relevant traits to the fore in building selection indexes for Bayer.
“This is an exciting project for us, where we can contribute to Bayer’s track record of generating value for agriculture and society through their best-in-class seed products.”
AbacusBio is an international leader in the application of science and technology in agriculture, horticulture, forestry, and aquaculture. Dr Tim Byrne recently took part in a Farmers Guardian/New Zealand Trade and Enterprise webinar on NZ agritech for the UK market.
Visit the series homepage for more information